Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04602117
Title Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors QuantumLeap Healthcare Collaborative
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.